Related Experiment Video
Updated: May 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
In vitro radiosensitization by pentoxifylline does not depend on p53 status
John M Akudugu1, Antonio M Serafin, Lothar J F Böhm
1Radiobiology Unit, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa. jakudugu@sun.ac.za
Pentoxifylline enhances radiation therapy by increasing G2/M cell cycle arrest, independent of p53 status. Its effectiveness relies on the extent of this radiation-induced block, offering potential for targeted cancer treatments.
Area of Science:
- Radiobiology
- Molecular Oncology
- Cell Cycle Regulation
Background:
- The mechanism of pentoxifylline's radiosensitizing effect is debated.
- Previous hypotheses suggested preferential sensitization of p53 mutant cells.
Purpose of the Study:
- To investigate the role of pentoxifylline in radiosensitization.
- To determine the p53 dependency of pentoxifylline's radiosensitizing effects.
- To correlate radiosensitization with cell cycle arrest.
Main Methods:
- Tested six human glioblastoma cell lines.
- Assessed cell survival, mitotic activity, and DNA damage (micronucleus formation) after gamma radiation and pentoxifylline treatment.
- Utilized colony-forming and cytokinesis-block assays.
Main Results:
- A 4 Gy radiation dose induced G2/M blocks in both p53 mutant and wild-type cells.
- Pentoxifylline addition at the G2/M block peak reduced cell survival independently of p53.
- Radiosensitization correlated with the magnitude of the G2/M block.
Conclusions:
- Pentoxifylline's radiosensitizing effect is p53-independent.
- Effectiveness is linked to the proportion of cells arrested in G2/M phase.
- Findings support using G2/M checkpoint abrogators in specific cancer therapies.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

